{
  "resourceType" : "ResearchStudy",
  "id" : "586129",
  "meta" : {
    "versionId" : "4",
    "lastUpdated" : "2026-07-30T12:54:53.701Z",
    "profile" : ["http://hl7.org/fhir/uv/ebm/StructureDefinition/research-study-site"]
  },
  "language" : "en",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ResearchStudy 586129</b></p><a name=\"586129\"> </a><a name=\"hc586129\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 4; Last updated: 2026-07-30 12:54:53+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-research-study-site.html\">ResearchStudySite</a></p></div><p><b>ArtifactPublicationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}\">Active</span></p><p><b>Artifact Author</b>: Brian S. Alper, MD, MSPH: </p><p><b>url</b>: <a href=\"https://fevir.net/resources/ResearchStudy/586129\">https://fevir.net/resources/ResearchStudy/586129</a></p><p><b>identifier</b>: FEvIR Object Identifier/586129</p><p><b>title</b>: Example of a ResearchStudySite</p><p><b>partOf</b>: <a href=\"ResearchStudy-583768.html\">Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial</a></p><p><b>citeAs</b>: </p><div><p>Example of a ResearchStudySite [Database Entry: FHIR ResearchStudy Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 586129. Revised 2026-07-30. Available at: https://fevir.net/resources/ResearchStudy/586129. Computable resource at: https://fevir.net/resources/ResearchStudy/586129#json.</p>\n</div><p><b>status</b>: Active</p><p><b>description</b>: </p><div><p>This is an example of a ResearchStudySite Profile in the EBMonFHIR IG. The ResearchStudySite.partOf references the parent research study, and the ResearchStudySite Profile is mainly used for data that is site-specific, such as recruiting status.</p>\n</div><p><b>site</b>: <a href=\"#hc586129/NCT05327010-Location-0\">Location City of Hope Comprehensive Cancer Center</a></p><h3>ProgressStatuses</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>State</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/research-study-status recruiting}\">Recruiting</span></td></tr></table><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Location #NCT05327010-Location-0</b></p><a name=\"586129/NCT05327010-Location-0\"> </a><a name=\"hc586129/NCT05327010-Location-0\"> </a><p><b>name</b>: City of Hope Comprehensive Cancer Center</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Purpose</b></td><td><b>Name</b></td><td><b>Telecom</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/research-study-party-role general-contact}\">General contact</span></td><td>Site Public Contact</td><td>ph: 800-826-4673, <a href=\"mailto:becomingapatient@coh.org\">becomingapatient@coh.org</a></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/research-study-party-role primary-investigator}\">Principal investigator</span></td><td>Irene M. Kang</td><td> </td></tr></table><p><b>address</b>: Duarte California 91010 United States </p><h3>Positions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Longitude</b></td><td><b>Latitude</b></td></tr><tr><td style=\"display: none\">*</td><td>-117.97729</td><td>34.13945</td></tr></table></blockquote></div>"
  },
  "contained" : [{
    "resourceType" : "Location",
    "id" : "NCT05327010-Location-0",
    "name" : "City of Hope Comprehensive Cancer Center",
    "contact" : [{
      "purpose" : {
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/research-study-party-role",
          "code" : "general-contact",
          "display" : "General contact"
        }]
      },
      "name" : [{
        "text" : "Site Public Contact"
      }],
      "telecom" : [{
        "system" : "phone",
        "value" : "800-826-4673"
      },
      {
        "system" : "email",
        "value" : "becomingapatient@coh.org"
      }]
    },
    {
      "purpose" : {
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/research-study-party-role",
          "code" : "primary-investigator",
          "display" : "Principal investigator"
        }]
      },
      "name" : [{
        "text" : "Irene M. Kang"
      }]
    }],
    "address" : {
      "city" : "Duarte",
      "state" : "California",
      "postalCode" : "91010",
      "country" : "United States"
    },
    "position" : {
      "longitude" : -117.97729,
      "latitude" : 34.13945
    }
  }],
  "extension" : [{
    "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
        "code" : "active",
        "display" : "Active"
      }]
    }
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
    "valueContactDetail" : {
      "name" : "Brian S. Alper, MD, MSPH"
    }
  }],
  "url" : "https://fevir.net/resources/ResearchStudy/586129",
  "identifier" : [{
    "type" : {
      "coding" : [{
        "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
        "code" : "ACSN",
        "display" : "Accession ID"
      }],
      "text" : "FEvIR Object Identifier"
    },
    "system" : "https://fevir.net/FOI",
    "value" : "586129",
    "assigner" : {
      "display" : "Computable Publishing LLC"
    }
  }],
  "title" : "Example of a ResearchStudySite",
  "partOf" : [{
    "reference" : "ResearchStudy/583768",
    "type" : "ResearchStudy",
    "display" : "Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial"
  }],
  "citeAs" : "Example of a ResearchStudySite [Database Entry: FHIR ResearchStudy Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 586129. Revised 2026-07-30. Available at: https://fevir.net/resources/ResearchStudy/586129. Computable resource at: https://fevir.net/resources/ResearchStudy/586129#json.",
  "status" : "active",
  "description" : "This is an example of a ResearchStudySite Profile in the EBMonFHIR IG. The ResearchStudySite.partOf references the parent research study, and the ResearchStudySite Profile is mainly used for data that is site-specific, such as recruiting status.",
  "site" : [{
    "reference" : "#NCT05327010-Location-0",
    "type" : "Location"
  }],
  "progressStatus" : [{
    "state" : {
      "coding" : [{
        "system" : "http://terminology.hl7.org/CodeSystem/research-study-status",
        "code" : "recruiting",
        "display" : "Recruiting"
      }]
    }
  }]
}